MedPath

Comparison of Duloxetine and Methylphenidate in treatment of children with Attention Deficit/ Hyperactivity Disorder

Not Applicable
Conditions
Attention Deficit Hyperactivity Disorder(ADHD).
Attention deficit: disorder with hyperactivity hyperactivity disorder syndrome with hyperactivity
Registration Number
IRCT2012101510363N2
Lead Sponsor
niversity of Social Welfare and Rehabilitation Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Inclusion criteria : ADHD diagnosis according to DSM-IV-TR that is applied by two psychiatrists; age between 6-12 years old
Exclusion criteria : mental retardation; history of heart disease; drug sensitivity; comorbidity of severe mental illnesses such as bipolar disorder, major depressive disorder, conduct disorder, psychosis; history of seizure.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of ADHD symtoms. Timepoint: each two weeks. Method of measurement: ADHD rating scale/ Conners rating scale-parent form.
Secondary Outcome Measures
NameTimeMethod
Drug side effects, severity of depressive and anxiety symptoms. Timepoint: beginning and end of trial. Method of measurement: checklist of side effects- CDI-RCMAS.
© Copyright 2025. All Rights Reserved by MedPath